Completed PHASE3 INTERVENTIONAL 1-arm NCT00863785

Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone (HAA-NAC)

Treatment of Acute Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone: a French Multicentre Randomized Controlled Study.

Sponsor: Centre Hospitalier Universitaire, Amiens

Conditions Alcoholic Hepatitis

Interventions Corticoids plus N Acetyl Cysteine

Updated 6 times since 2017 Last updated: Oct 19, 2009 Started: Apr 30, 2004 Primary completion: Aug 31, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Alcoholic Hepatitis, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire, Amiens and has accumulated 6 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire, Amiens

Data source: Centre Hospitalier Universitaire, Amiens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbeville, France , Beauvais, France , Besançon, France , Caen, France , Cambrai, France , Compiègne, France , Lens, France , Paris, France , Reims, France , Rouen, France and 2 more locations